Key facts
- This page summarizes Pamela Vig's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Jun 2024, 17:15.
Pamela Vig - 24 Jun 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)
- Reporting relationship
- CHIEF SCIENTIFIC OFFICER
- Issuer ticker
- MIRM
- Reported as of
- 24 Jun 2024
- Net transaction value
- -$949,285
- SEC form
- 4
- Accepted by SEC
- 25 Jun 2024, 17:15:54 UTC
- Prior SEC filing
- 16 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Judit Ryvkin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Pamela Vig filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 25 Jun 2024.
Change
- Previous filing in this sequence was filed on 16 May 2024.
- Current net transaction value: -$949,285.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRM
transaction
Common Stock
Options Exercise
- Transaction value
- $89,721
- Shares
- +30,559
- Change %
- +112%
- Price
- $2.94
- Shares after
- 57,965
- Date
- 24 Jun 2024
- Ownership
- Direct
MIRM
transaction
Common Stock
Sale
- Transaction value
- $1,039,006
- Shares
- -30,559
- Change %
- -53%
- Price
- $34.00
- Shares after
- 27,406
- Date
- 24 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
MIRM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,000
- Date
- 24 Jun 2024
- Ownership
- By The Vig-Ancock Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MIRM
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -30,559
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 125,691
- Date
- 24 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,559
- Exercise price
- $2.94
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted in March 2024.
Footnote F2
The stock option is fully vested.